Changes to the status of several medications including skeletal muscle relaxants in the ODG prescription drug formulary will likely have an impact in states that include the formulary in their treatment guidelines, Optum Workers’ Comp and Auto No-Fault said Wednesday.
The ODG formulary designates medications that are preferred as first-line treatment options as “Y” drugs. Medications designated as an “N” drug are not recommended as the first-line treatment. Some states require prior authorization for N drugs only, while others require pre-authorization for anything not designated as a “Y” drug.
Skeletal muscle relaxants, including chlorzoxazone, metaxalone and tizanidine, are changing from a “Y” drug to an “N” drug.
“In states following the ODG drug formulary for their workers’ compensation claimants’ medication treatments, a shift in the utilization of these medications is expected,” Optum said.
May 13-15, 2024
Join us May 13–15, 2024, for NCCI's Annual Insights Symposium (AIS) 2024, the industry’s premier e …
Jul 29 – Aug 2, 2024
SAVE THE DATE! 76th Annual SAWCA Convention July 29 – August 2, 2024 Hotel Effie Sandestin 1 Grand …
Aug 14-17, 2024
California Society of Industrial Medicine and Surgery (CSIMS) is combining its two conferences, PI …
No Comments
Log in to post a comment